Compare · RMD vs SONX
RMD vs SONX
Side-by-side comparison of ResMed Inc. (RMD) and Sonendo Inc. (SONX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RMD and SONX operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- RMD is the larger of the two at $28.02B, about 145.5x SONX ($192.5M).
- RMD has hit the wire 6 times in the past 4 weeks while SONX has been quiet.
- RMD has more recent analyst coverage (25 ratings vs 6 for SONX).
- Company
- ResMed Inc.
- Sonendo Inc.
- Price
- $193.21-1.43%
- $0.23-5.15%
- Market cap
- $28.02B
- $192.5M
- 1M return
- -6.57%
- -
- 1Y return
- -23.07%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 6
- 0
- Recent ratings
- 25
- 6
ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Sonendo Inc.
Sonendo, Inc. develops, manufactures, and sells devices for root canal therapy in the United States and Canada. It offers GentleWave, a device to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is based in Laguna Hills, California.
Latest RMD
- Global General Counsel Rider Michael J covered exercise/tax liability with 269 units of ResMed Common Stock, decreasing direct ownership by 3% to 9,488 units (SEC Form 4) (tax withholding)
- Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
- Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
- SEC Form SD filed by ResMed Inc.
- Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
- Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,037,233 worth of ResMed Common Stock (4,991 units at $207.82) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 3 filed by new insider Bloomer Aaron
- SEC Form 4 filed by Chief Financial Officer Sandercock Brett
- SEC Form 8-K filed by ResMed Inc.
Latest SONX
- Amendment: SEC Form SCHEDULE 13G/A filed by Sonendo Inc.
- Sonendo Strengthens Leadership Team With Promotion of John McGaugh to Chief Operating Officer
- Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance
- Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance
- SEC Form D filed by Sonendo Inc.
- Sonendo, Inc. Announces $5.0 Million Private Placement
- SEC Form 10-K filed by Sonendo Inc.
- Sonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
- SEC Form EFFECT filed by Sonendo Inc.
- SEC Form EFFECT filed by Sonendo Inc.